Integrated Wealth Concepts LLC Sells 9,348 Shares of iShares Biotechnology ETF $IBB

Integrated Wealth Concepts LLC lowered its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 52.2% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 8,547 shares of the financial services provider’s stock after selling 9,348 shares during the period. Integrated Wealth Concepts LLC’s holdings in iShares Biotechnology ETF were worth $1,626,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Community Bank N.A. grew its holdings in iShares Biotechnology ETF by 5.2% during the 2nd quarter. Community Bank N.A. now owns 1,483 shares of the financial services provider’s stock valued at $282,000 after buying an additional 73 shares in the last quarter. RFG Advisory LLC bought a new stake in shares of iShares Biotechnology ETF during the second quarter valued at approximately $349,000. NewEdge Advisors LLC lifted its holdings in shares of iShares Biotechnology ETF by 33.2% in the second quarter. NewEdge Advisors LLC now owns 19,622 shares of the financial services provider’s stock worth $3,732,000 after buying an additional 4,888 shares in the last quarter. IFP Advisors Inc lifted its holdings in shares of iShares Biotechnology ETF by 39.3% in the second quarter. IFP Advisors Inc now owns 49,988 shares of the financial services provider’s stock worth $9,507,000 after buying an additional 14,115 shares in the last quarter. Finally, Baird Financial Group Inc. lifted its holdings in shares of iShares Biotechnology ETF by 7.5% in the second quarter. Baird Financial Group Inc. now owns 22,980 shares of the financial services provider’s stock worth $4,371,000 after buying an additional 1,602 shares in the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ:IBB opened at $202.00 on Wednesday. The firm has a fifty day moving average price of $199.68 and a 200 day moving average price of $181.80. iShares Biotechnology ETF has a fifty-two week low of $138.79 and a fifty-two week high of $217.12.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, September 18th. Shareholders of record on Tuesday, September 15th will be paid a $0.0112 dividend. The ex-dividend date is Tuesday, September 15th. This represents a $0.04 annualized dividend and a yield of 0.0%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.